ACKR3 expression at the protein level was elevated in aggressive prostate tumors, where ACKR3 can increase the expression of pro-angiogenic factors such as CXCL8 and VEGF [301] and support the transendothelial migration of cancer cells [302]. This evidence concerns the gene CXCL8 and cancer.